| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 6,441,000 | 9,140,000 | 16,109,000 | 16,084,000 | | Cost of Revenue | 5,350,000 | 5,552,000 | 16,140,000 | 14,361,000 | | | Gross Profit | 1,091,000 | 3,588,000 | (31,000) | 1,723,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 816,000 | 2,925,000 | (1,066,000) | 1,481,000 | | Non Recurring | 79,000 | 229,000 | 17,000 | (18,000) | | Others | 125,000 | 134,000 | 129,000 | 124,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 71,000 | 300,000 | 889,000 | 136,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (26,000) | 26,000 |
-
| | Earnings Before Interest And Taxes | 71,000 | 274,000 | 915,000 | 136,000 | | Interest Expense | 21,000 | (11,000) | 44,000 | 20,000 | | Income Before Tax | 50,000 | 285,000 | 871,000 | 116,000 | | Income Tax Expense | (1,000) | 81,000 | 322,000 | 34,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 51,000 | 204,000 | 549,000 | 82,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 51,000 | 204,000 | 549,000 | 82,000 | | Preferred Stock And Other Adjustments | (39,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,000 | $204,000 | $549,000 | $82,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
